Steven L. Lewis, MD, FAAN
Associate Chair, Professor, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois
Dr Lewis has received personal compensation from the American Academy of Neurology for serving as Editor-in-Chief of
Continuum: Lifelong Learning in
and for activities related to
Audio and for activities related to his role as a director of the American Board of Psychiatry and Neurology.
Dr Lewis has received royalty payments from Wolters Kluwer for the books
Field Guide to the Neurologic Examination and
Neurology for the Non-Neurologist and from Wiley-Blackwell for the book
Neurological Disorders Due to Systemic Disease. Dr. Lewis is an Elected Trustee of the World Federation of Neurology and serves as Editor-in-Chief of World Neurology.
Associate Editor of Ethics and Medicolegal Issues
Joseph S. Kass, MD, JD, FAAN
Associate Professor of Neurology, Psychiatry, and Medical Ethics; Vice Chair for Education, Department of Neurology; Associate Dean of Student Affairs, Baylor College of Medicine, Houston, Texas
Relationship Disclosure: Dr Kass serves as associate editor of ethical and medicolegal issues for Continuum and as an associate editor for Continuum
Audio. Dr Kass has received personal compensation for CME and grand rounds lectures from MCE Conferences; Medical Education Speakers Network; and PrimeMed Medical Group, and has received personal compensation for expert testimony in legal cases involving personal injury, defamation, and malpractice.
Associate Editor of Practice
Anna D. Hohler, MD, FAAN
Assistant Professor of Neurology, Boston University Medical Campus, Boston, Massachusetts
Dr Hohler reports no disclosure.
Associate Editor of Coding
Laura B. Powers, MD, FAAN
Retired from private practice
Dr Powers receives honoraria from the American Academy of Neurology for speaking engagements, and serves as the deputy editor for
Neurology: Clinical Practice.
Associate Editor of Child Neurology
Jonathan W. Mink, MD, PhD, FAAN
Professor of Neurology, Neurobiology and Anatomy, Brain and Cognitive Sciences, and Pediatrics; Chief, Division of Child Neurology; Vice Chair, Department of Neurology, University of Rochester Medical Center, Rochester, New York
Dr Mink serves as a member of the scientific advisory board of Censa Pharmaceuticals; as chair of the data and safety monitoring board of Edison Pharmaceuticals, Inc; as a member of the national advisory council of the National Institute of Neurological Disorders and Stroke, and as a member of the scientific advisory board of the Tourette Association of America. Dr Mink serves as associate editor of Neurology and receives royalties from Elsevier and John Wiley and Sons, Inc. Dr Mink has served as a consultant for BioMarin and Medtronic and has received grants from Abeona Therapeutics, Batten Disease Support and Research Association, Batten Research Alliance, and the National Institute of Health.
Associate Editor of Neuroimaging
Laszlo L. Mechtler, MD, FAAN, FASN
Professor, Chief, Department of Neuro-oncology, Roswell Park Cancer Institute; Clinical Associate Professor of Neurology, School of Biomedical Sciences, State University of New York at Buffalo; Vice President, Director, Brain Tumor Center, Director, Headache Clinic, Dent Neurologic Institute, Buffalo, New York
Dr Mechtler has received personal compensation for speaking engagements with Allergan, Inc; Avanir Pharmaceuticals, Inc; and Teva Pharmaceutical Industries Ltd, and has received research support from Alder Biopharmaceuticals Inc; Allergan; Amgen Inc; Autonomic Technologies; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd; and Vascular Biogenics.
Associate Editor of Self-Assessment and CME
Joseph E. Safdieh, MD, FAAN
Vice Chairman for Education and Associate Professor of Neurology, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, New York
Relationship Disclosure: Dr Safdieh reports no disclosure.
Continuum Audio Editor
Aaron E. Miller, MD, FAAN
Medical Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis; Professor of Neurology, Mount Sinai School of Medicine, New York, New York
Dr. Miller received personal compensation for consulting and/or speaking engagements from Accordant, Acorda Therapeutics, Alkermes, Biogen, Gelgene, EMD Serono, F. Hoffmann-La Roche Ltd, Novartis, and Sanofi Genzyme. Dr Miller receives personal compensation from the American Academy of Neurology for serving as editor of
Continuum Audio and research support for participation in clinical trials from Biogen, F. Hoffmann-La Roche Ltd, Genentech Inc, Novartis, Mallinckrodt Pharmaceuticals, and MedDay.
Marketa Marvanova, PharmD, PhD, CGP, BCPP
Associate Professor of Pharmacy Practice, Chicago State University College of Pharmacy, Chicago, Illinois
Relationship Disclosure: Dr Marvanova reports no disclosure.
Hannah R. Briemberg, MD, FRCPC
Director, Neurology Residency Program, Clinical Assistant Professor, The University of British Columbia, Vancouver, British Columbia, Canada
Dr Briemberg receives grant support from the ALS Society of BC, the ALS Society of Canada, the Canadian Institutes of Health Research, and the University of Calgary. Dr Briemberg receives royalties from UptoDate, Inc.
Shannon M. Kilgore, MD, FAAN
Clinical Assistant Professor, Stanford University, Stanford, California; Assistant Chief of Neurology, VA Palo Alto Health Care System, Palo Alto, California
Dr. Kilgore serves as an advisory board member of Cala Health, Inc.
Kerry H. Levin, MD, FAAN
Chairman, Department of Neurology; Director, Neuromuscular Center; Professor of Medicine (Neurology), Cleveland Clinic, Cleveland, Ohio
Dr. Levin serves on the board of directors of the American Board of Psychiatry and Neurology and has received royalties from Elsevier and UptoDate, Inc.
Karlo J. Lizarraga, MD, MS
Movement Disorders Fellow, University of Toronto Movement Disorders Center, Toronto, Ontario, Canada
Relationship Disclosure: Dr Lizarraga is the founder and CEO of La Escuelita AQMED in Peru.
Alejandro A. Rabinstein, MD, FAAN
Professor of Neurology, Mayo Clinic, Rochester, Minnesota
Relationship Disclosure: Dr Rabinstein has received royalty payments from Elsevier and Oxford University Press and research support from DJO Global.
Daniel B. Simmons, MD
Clinical Neurophysiology Fellow, University of Rochester Medical Center, Rochester, New York
Relationship Disclosure: Dr Simmons reports no disclosure.
A. Gordon Smith, MD, FAAN
Professor and Vice Chair of Research; Chief, Division of Neuromuscular Medicine, University of Utah School of Medicine, Salt Lake City, Utah
Relationship Disclosure: Dr Smith serves as a consultant for Allergan, Gelgene Corporation, CSL Behring, and Grifols. Dr Smith has received personal compensation from the American Academy of Neurology for serving as an editor of NeuroLearn and has served as an expert witness on cases involving peripheral nerve disorders. Dr Smith receives research support from the National Institutes of Health.
Erik K. St. Louis, MD, MS, FAAN
Co-director, Mayo Center for Sleep Medicine in Minnesota; Associate Professor of Neurology, Consultant in Medicine and Neurology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota
Dr St. Louis has received personal compensation for serving as a consultant in clinical trial design for Axovant Sciences Ltd, for serving on the data safety monitoring board of Inspire Inc, and has received research/grant support from Axovant Sciences Ltd; Mayo Clinic Center for Clinical and Translational Science; Merck & Co. Inc; the Michael J. Fox Foundation; the National Institutes of Health/National Heart, Lung, and Blood Institute; and Sunovion Pharmaceuticals Inc
Allison L. Weathers, MD, FAAN
Associate Chief Medical Information Officer, Cleveland Clinic, Beachwood, Ohio
Relationship Disclosure: Dr Weathers has received honoraria for grand rounds and lectures from the Los Angeles Neurological Society, the North Carolina Neurological Society, and the Wake Forest Neurology Department. Dr Weathers receives travel reimbursement for participation on American Academy of Neurology (AAN) committees, has received honoraria for presenting at the AAN Annual Meeting, and serves as chair of the Adult Neuroscience Specialty Steer Board at Epic Pharma, LLC.